HIF-1?-IN-8

• Target:

  HIF/HIF Prolyl-Hydroxylase|||I?B/IKK|||Apoptosis|||NF-?B|||ROS

• Related Pathways:

  NF-?B|||Chromatin/Epigenetic|||Metabolism|||Apoptosis|||Immunology/Inflammation

• Bioactivity:

  HIF-1?-IN-8 is an orally active inhibitor of HIF-1? with an IC50 of 2.02 ?M. It effectively suppresses the expression of inflammatory factors such as IL-6 and NO, reduces hypoxia-induced ROS production and apoptosis in C8-D1A cells, and inhibits the HIF-1?/IKK?/NF-?B signaling pathway. Additionally, it decreases the expression of proteins related to blood-brain barrier permeability. In a high-altitude cerebral edema (HACE) mouse model, HIF-1?-IN-8 lowers brain water content and oxidative stress levels. This compound is suitable for researching high-altitude cerebral edema (HACE) .

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C